Hense H W, Tennis P
GSF-Medis Institute, Department of Epidemiology, Neuherberg, FRG.
Eur J Clin Pharmacol. 1990;39(1):1-7. doi: 10.1007/BF02657047.
In the MONICA Augsburg project, a cohort of 3324 men and women randomly selected from the population (aged 30 to 64 y) was surveyed in 1984/85 and in 1987/88. Their antihypertensive medication as well as their demographic characteristics, blood pressure values, and awareness of hypertension were assessed at each visit in an identical manner. In 1984/85 the prevalence of antihypertensive drug use in the cohort was 7.8% (n = 260). In 1987/88, 204 of the hypertensives were still being treated (continuously treated hypertensives) and there were 167 newly treated hypertensives, thus increasing the prevalence of antihypertensive drug use to 11.2%. Of the 204 continuously treated hypertensives, 45.6% had changed their antihypertensive medication over the three-year follow-up period. Combinations with diuretics (except those containing calcium antagonists or ACE-inhibitors) had largely been discontinued, and the prevalence of calcium antagonist mono- and combination therapy had markedly increased from 84/85 to 87/88. Men were treated more frequently with recently introduced antihypertensive agents than women. Newly treated hypertensives (n = 167) showed antihypertensive treatment patterns reflecting the changes observed in continuously treated hypertensives. Triple drug combinations, mostly in fixed ratios, were being taken by approximately 25% of all hypertensives at each visit. Prospective analysis revealed an underlying discontinuation rate of 49%. It is concluded that the epidemiology of antihypertensive therapy in individuals and in the community is subject to rapid changes and various influences. Cohort studies of treated antihypertensive individuals offer a more comprehensive understanding of its determinants.
在奥格斯堡MONICA项目中,1984/85年和1987/88年对从人群中随机选取的3324名年龄在30至64岁之间的男性和女性进行了调查。每次访视时,均以相同方式评估他们的抗高血压药物治疗情况以及人口统计学特征、血压值和高血压知晓情况。1984/85年,该队列中抗高血压药物的使用率为7.8%(n = 260)。1987/88年,204名高血压患者仍在接受治疗(持续治疗的高血压患者),新增167名接受治疗的高血压患者,因此抗高血压药物的使用率增至11.2%。在204名持续治疗的高血压患者中,45.6%在三年随访期内更换了抗高血压药物。与利尿剂的联合使用(不包括含钙拮抗剂或血管紧张素转换酶抑制剂的联合用药)大多已停用,钙拮抗剂单药治疗和联合治疗的使用率从84/85年到87/88年显著增加。与女性相比,男性使用新推出的抗高血压药物的频率更高。新接受治疗的高血压患者(n = 167)的抗高血压治疗模式反映了持续治疗的高血压患者中观察到的变化。每次访视时,约25%的高血压患者采用三联药物联合治疗,大多为固定比例。前瞻性分析显示潜在停药率为49%。结论是,个体和社区中抗高血压治疗的流行病学情况会迅速变化并受到多种影响。对接受抗高血压治疗的个体进行队列研究有助于更全面地了解其决定因素。